Fecobionics device for mapping colonic and anorectal neuromuscular function

用于绘制结肠和肛门直肠神经肌肉功能的 Fecobionics 装置

基本信息

项目摘要

NEW ABSTRACT The colon and anorectum have complex composition. Methods to study neuromuscular interactions and activity in health and gastrointestinal (GI) disease have been limited due to difficult access and lack of appropriate technologies. Many aspects of colonic mechanosensory physiology are still not well understood including the influence of enteric circuits and reflexes, and extrinsic nerve function in the various segments of the colon. The need for new technology and a better understanding of the neuromuscular function is substantial. A significant problem is a lack of physiologically-relevant and practical test for identifying the underlying mechanism(s). Hence, the overall objective is to validate a fully integrative dynamic tool that mimics feces transport in the lower GI tract. Accordingly, the following tasks are proposed: 1) Optimization of a wireless development of Fecobionics device and System for neuromuscular function studies of the colon. Milestone: Wireless device that can record during transport through colon and anorectum; 2) Conduct safety and performance studies in dogs (including IDE approval): Milestone: Studies that demonstrates safety and performance of the device under different neuromuscular conditions; and 3) Develop a validated mathematical model of the lower GI tract. Milestone: Geometric and functional mathematical model for colonic transport and defecation. The proposed technology (Fecobionics) is a simulated electronic feces that has the consistency and shape of normal stool. The measured variables in Fecobionics include multiple pressures, shape changes, velocity and orientation. Hence, it will be feasible to map and describe objectively (without disturbing the colonic transport and defecation processes) the transport characteristics and neuromuscular signatures during colonic transport and initial entry from the rectum into the relaxing anal canal. This unique device will provide new neuromuscular signatures of the lower GI tract under normal circumstances, and during intervention with enteric and peripheral nerve activity to enhance our understanding of physiological and pathophysiological mechanisms involved in the lower GI tract neuromuscular function. In line with SPARC mission, we intend to provide a new technology for lower GI testing, simulating normal stool transport and defecation with a bionics device. This technology will replace several current tests, because it provides an integrated frame work for assessing function and obviates the need for multiple tests of function. The central premise is that a novel and unique Fecobionics device that mimics natural lower GI transport will provide new mechanistic insights regarding colonic and anorectal physiology when compared to standard tests and facilitate development of new diagnostics for lower GI disorders. The significance is to address the major gaps in knowledge by developing a safe, low cost, less invasive, low risk, radiation-free device, and test its ability to provide new understanding of colonic neuromuscular and defecation function. This may later facilitate development of diagnostic and therapeutic tools that will reduce healthcare costs. An additional task of this project is to develop software, called Software for Organizing Data Automatically (SODA), that will help SPARC investigators navigate the data organization and sharing processes through interactive tools and automation. Milestones for this task include the development of 1) A Python module, 2) An Interactive User Interface, and 3) User support tools for the software.
新摘要 结肠和肛门直肠有复杂的成分。由于获取困难和缺乏适当的技术,研究健康和胃肠道(GI)疾病中的神经肌肉相互作用和活动的方法一直受到限制。结肠机械感觉生理学的许多方面仍不是很清楚,包括肠路和反射的影响,以及结肠不同节段的外源性神经功能。对新技术和更好地了解神经肌肉功能的需求是巨大的。一个重要的问题是缺乏与生理相关的实用测试来确定潜在的机制(S)。因此,总体目标是验证一种完全集成的动态工具,该工具可以模拟下胃肠道中的粪便传输。因此,提出了以下工作:1)优化用于结肠神经肌肉功能研究的无线仿生学设备和系统。里程碑:可以在通过结肠和肛门直肠的运输过程中进行记录的无线设备;2)在狗身上进行安全和性能研究(包括IDE批准):里程碑:证明该设备在不同神经肌肉条件下的安全性和性能的研究;以及3)开发经过验证的下胃肠道的数学模型。里程碑:结肠运输和排便的几何和功能数学模型。所提出的技术(粪便仿生学)是一种模拟的电子粪便,具有正常粪便的稠度和形状。生物仿生学中的测量变量包括多个压力、形状变化、速度和方向。因此,在不干扰结肠运输和排便过程的情况下,客观地标测和描述结肠运输和从直肠进入松弛肛管的最初过程中的运输特征和神经肌肉特征是可行的。这一独特的设备将在正常情况下以及在肠道和周围神经活动干预期间提供下消化道的新的神经肌肉信号,以增强我们对下消化道神经肌肉功能所涉及的生理和病理生理机制的了解。根据SPARC的任务,我们打算提供一种新的技术,用于较低的GI测试,用仿生学设备模拟正常的大便运输和排便。这项技术将取代目前的几种测试,因为它提供了一个评估功能的完整框架,并消除了对功能进行多次测试的需要。中心前提是,与标准测试相比,一种新颖而独特的仿生设备模拟了自然的低GI运输,将提供关于结肠和肛门直肠生理的新的机械学见解,并促进针对低GI疾病的新诊断方法的开发。其意义在于通过开发一种安全、低成本、低创伤、低风险、无辐射的设备来解决知识的主要差距,并测试其提供对结肠神经肌肉和排便功能的新理解的能力。这可能会在以后促进诊断和治疗工具的开发,从而降低医疗成本。该项目的另一项任务是开发名为自动组织数据软件(SODA)的软件,该软件将通过交互工具和自动化帮助SPARC调查人员导航数据组织和共享过程。这项任务的里程碑包括开发1)Python模块,2)交互式用户界面,以及3)软件的用户支持工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hans Gregersen其他文献

Hans Gregersen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hans Gregersen', 18)}}的其他基金

Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation.
Fecobionics 监测和预测排便阻塞患者生物反馈治疗结果。
  • 批准号:
    10568352
  • 财政年份:
    2023
  • 资助金额:
    $ 155.62万
  • 项目类别:
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics
使用fecobionics治疗大便失禁的病理生理学、诊断和生物反馈治疗
  • 批准号:
    10670930
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics
使用fecobionics治疗大便失禁的病理生理学、诊断和生物反馈治疗
  • 批准号:
    10521701
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
Defecation mechanisms and subtyping of constipation patients with Fecobionics
Fecobionics对便秘患者的排便机制和分型
  • 批准号:
    10211784
  • 财政年份:
    2021
  • 资助金额:
    $ 155.62万
  • 项目类别:
Defecation mechanisms and subtyping of constipation patients with Fecobionics
Fecobionics对便秘患者的排便机制和分型
  • 批准号:
    10686246
  • 财政年份:
    2021
  • 资助金额:
    $ 155.62万
  • 项目类别:
Defecation mechanisms and subtyping of constipation patients with Fecobionics
Fecobionics对便秘患者的排便机制和分型
  • 批准号:
    10418687
  • 财政年份:
    2021
  • 资助金额:
    $ 155.62万
  • 项目类别:
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence
大便失禁患者骶神经调节的神经生理机制
  • 批准号:
    10226390
  • 财政年份:
    2019
  • 资助金额:
    $ 155.62万
  • 项目类别:
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence
大便失禁患者骶神经调节的神经生理机制
  • 批准号:
    9808053
  • 财政年份:
    2019
  • 资助金额:
    $ 155.62万
  • 项目类别:
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence
大便失禁患者骶神经调节的神经生理机制
  • 批准号:
    10446018
  • 财政年份:
    2019
  • 资助金额:
    $ 155.62万
  • 项目类别:
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence
大便失禁患者骶神经调节的神经生理机制
  • 批准号:
    10347628
  • 财政年份:
    2019
  • 资助金额:
    $ 155.62万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 155.62万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 155.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 155.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 155.62万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 155.62万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了